KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Capital Expenditures (2016 - 2025)

Chemed (CHE) has 17 years of Capital Expenditures data on record, last reported at $16.3 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 28.11% year-over-year to $16.3 million; the TTM value through Dec 2025 reached $62.8 million, up 26.78%, while the annual FY2025 figure was $62.8 million, 26.78% up from the prior year.
  • Capital Expenditures reached $16.3 million in Q4 2025 per CHE's latest filing, down from $17.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $18.3 million in Q4 2022 and bottomed at $10.9 million in Q3 2021.
  • Average Capital Expenditures over 5 years is $14.3 million, with a median of $13.5 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: crashed 35.49% in 2023, then surged 42.9% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $14.2 million in 2021, then rose by 28.56% to $18.3 million in 2022, then plummeted by 35.49% to $11.8 million in 2023, then increased by 8.34% to $12.8 million in 2024, then rose by 28.11% to $16.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $16.3 million in Q4 2025, $17.4 million in Q3 2025, and $15.8 million in Q2 2025.